Skip to Main Navigation
Skip to Page Content

Nomination Summary for Flurazepam (N86331)

Nominated Substances: Flurazepam

Nomination Date: 03/00/1986

Nominator: FDA

Rationale: Flurazepam has extensive use and human exposure; lack of carcinogenicity data in rodents.

NTP Principles: Pre 1993 - 3, 4

Status: Selected

Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.

CASRN: 17617-23-1

Agent Name: Flurazepam

  • No studies are available.